COVID-19 Home Testing Kit Sales Skyrocket

Nearly one month after the existence of the easily transmissible Omicron variant was officially reported to the World Health Organization, retail sales in the Home Health Testing category are growing extremely quickly across the U.S.

According to shopper intelligence leader Catalina, for the latest week ending Dec. 18 sales of self-testing COVID-19 kits have shot up by 225% compared to six weeks ago, and by 71% vs. the week ending Dec. 11.

While COVID-19 self-testing kits did not exist before April 2021, the Home Health Testing category – which includes face masks – was up 370% for the week ending Dec. 18, 2021 vs. the same period a year ago, as the global pandemic continued to spread. When comparing purchase data to the same period two years ago, well before COVID-19 gained widespread awareness, category sales are up a whopping 1,442%.

With scientists continuing to make the case for face masks helping to stop the spread of COVID-19 as well as the Delta and Omicron variants, face mask sales have climbed 20 percent over the past six weeks. Even so, sales of face masks for the week ending Dec. 18 are down 25% vs. the same period a year ago as COVID-related restrictions have eased in business and social settings.

“To get an idea of the scale of COVID-19 home testing kits, out of nowhere they now make up 84% of the overall category, with face masks and all other home health testing kits each making up 8%,” said Catalina’s Chief Marketing Officer Marta Cyhan. “With more people now opting to take COVID tests at home before attending a social function, we anticipate sales in this category will continue to skyrocket in anticipation of gathering with family and friends for Christmas and New Year’s Eve.”

SourceCatalina

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”
Exit mobile version